Related Experiment Video
Updated: Apr 23, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Lenvatinib-associated hyaline occlusive glomerular microangiopathy.
Amir Daher1, Yael Kenig-Kozlovsky1,2, Marina Tchirkov1
1Department of Nephrology and Hypertension, Rambam Health Care Campus, Haifa, Israel.
Nephrologists managing cancer patients may encounter kidney issues from targeted therapies. Lenvatinib, a tyrosine kinase inhibitor, showed a unique glomerular injury pattern, suggesting reversible kidney damage linked to VEGF-VEGFR2 pathway inhibition.
Area of Science:
- Nephrology
- Oncology
- Pathology
Background:
- Cancer therapies like immunotherapies and oral small-molecule agents have improved outcomes but can cause severe adverse events.
- Nephrologists are crucial in managing renal complications in cancer patients undergoing treatment.
- Vascular Endothelial Growth Factor (VEGF) pathway inhibitors are increasingly used in cancer treatment.
Related Concept Videos
Diabetic Nephropathy
Renal Drug Excretion: Glomerular Filtration
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease II: Clinical Manifestations
Renal Drug Excretion: Tubular Secretion
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...

